Pfizer Boosts FY19 Adj. EPS Outlook

07:37 EDT 30 Apr 2019 | FinanzNachrichten

NEW YORK CITY (dpa-AFX) - While reporting financial results for the first quarter, Pfizer Inc. (PFE) on Tuesday raised its full-year 2019 guidance for adjusted earnings, while reaffirming its full...

Original Article: Pfizer Boosts FY19 Adj. EPS Outlook


More From BioPortfolio on "Pfizer Boosts FY19 Adj. EPS Outlook"

Quick Search

Relevant Topic

Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...